Protein Glycosylation as a Diagnostic and Prognostic Marker of Chronic Inflammatory Gastrointestinal and Liver Diseases

Gastroenterology. 2020 Jan;158(1):95-110. doi: 10.1053/j.gastro.2019.08.060. Epub 2019 Oct 15.

Abstract

Glycans are sequences of carbohydrates that are added to proteins or lipids to modulate their structure and function. Glycans modify proteins required for regulation of immune cells, and alterations have been associated with inflammatory conditions. For example, specific glycans regulate T-cell activation, structures, and functions of immunoglobulins; interactions between microbes and immune and epithelial cells; and malignant transformation in the intestine and liver. We review the effects of protein glycosylation in regulation of gastrointestinal and liver functions, and how alterations in glycosylation serve as diagnostic or prognostic factors, or as targets for therapy.

Keywords: Glycan; Glycome; Glycomic; Glycosylation; IBD; Liver Disease.

Publication types

  • Research Support, Non-U.S. Gov't
  • Research Support, U.S. Gov't, Non-P.H.S.
  • Review

MeSH terms

  • Biomarkers / metabolism
  • Gastrointestinal Diseases / diagnosis*
  • Gastrointestinal Diseases / mortality
  • Gastrointestinal Diseases / therapy
  • Gastrointestinal Tract / immunology
  • Gastrointestinal Tract / metabolism
  • Glycomics
  • Glycosylation / drug effects
  • Humans
  • Liver / immunology
  • Liver / metabolism
  • Liver Diseases / diagnosis*
  • Liver Diseases / mortality
  • Liver Diseases / therapy
  • Polysaccharides / metabolism
  • Prognosis
  • Proteomics
  • T-Lymphocytes / drug effects
  • T-Lymphocytes / immunology
  • T-Lymphocytes / metabolism
  • Time Factors

Substances

  • Biomarkers
  • Polysaccharides